Chiron continues to drop shoes

Chiron Corp. demonstrated with two new deals last week that it has a clearly delineated vision of where it wants to go and how it wants to get there.

Each deal represented a separate piece of CHIR's strategy. One, with Cephalon Inc., is to gain entry through strategic alliances into emerging technologies; the other, with Houghten Pharmaceuticals Inc., is to build strong patent positions around key technologies...